Drug firm Cadila Healthcare today reported 29 per cent dip in consolidated net profit to Rs 337.6 crore for the second quarter ended September 30, 2016-17.
The company had posted a net profit after taxes, minority interest and share of profit/(loss) of associates of Rs 475 crore, Cadila Healthcare said in a filing to BSE.
Consolidated total income from operations however rose to Rs 2,403.5 crore for the quarter under consideration as against Rs 2,394.9 crore for the same period of last fiscal, 2015-16.
Cadila stock was trading 4.24 per cent down at Rs 390.40 in the afternoon trade on BSE.
Disclaimer: No Business Standard Journalist was involved in creation of this content
